Omada Health, Inc.

Name: Omada Health, Inc. standardized financial statements, quarterly
Creator: Listed

OMDANasdaqCIK 1611115HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$87.8m, Q2 FY2026

Operating income$3.5m, Q2 FY2026

Net income$5.3m, Q2 FY2026

Omada Health, Inc., income statement, quarterly
Line item	Unit	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	period not labelled2024-12-31	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	not reported	41.2	45.5	48.0	55.0	61.4	68.0	75.8	78.0	87.8
Cost of revenue	$m	not reported	16.4	17.0	15.8	23.1	21.1	23.0	22.2	29.4	24.0
Gross profit	$m	not reported	24.8	28.6	32.1	31.9	40.3	45.1	53.7	48.7	63.8
Research and development	$m	not reported	9.0	8.9	9.2	8.8	10.0	10.3	11.6	12.7	14.6
Operating income	$m	not reported	(10.0)	(8.5)	(7.1)	(8.4)	(4.3)	(2.5)	3.3	(4.8)	3.5
Interest expense	$m	not reported	1.1	1.1	1.1	1.1	1.1	0.4	0.0	0.0	0.0
Income tax	$m	not reported	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income	$m	(19.0)	(10.7)	(9.2)	(8.3)	(9.4)	(5.3)	(3.2)	5.2	(3.0)	5.3
Diluted EPS	$ per share	not reported	(1.40)	(1.18)	not reported	(1.15)	(0.24)	(0.06)	not reported	(0.05)	0.08
Basic EPS	$ per share	not reported	(1.40)	(1.18)	not reported	(1.15)	(0.24)	(0.06)	not reported	(0.05)	0.09

Balance sheet

Cash and equivalents$221.7m, Q2 FY2026

Long-term debt$0, FY2025

Shareholders' equity$252.7m, Q2 FY2026

Omada Health, Inc., balance sheet, quarterly
Line item	Unit	period not labelled2022-12-31	period not labelled2023-12-31	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	period not labelled2024-12-31	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	not reported	not reported	not reported	not reported	not reported	76.4	not reported	223	199	222	212	222
Current assets	$m	not reported	not reported	not reported	not reported	not reported	113	not reported	271	255	273	269	295
Total assets	$m	not reported	not reported	not reported	not reported	not reported	151	not reported	303	287	305	303	328
Current liabilities	$m	not reported	not reported	not reported	not reported	not reported	54.0	not reported	58.0	70.1	75.7	68.7	75.5
Total liabilities	$m	not reported	not reported	not reported	not reported	not reported	86.3	not reported	88.8	70.1	75.7	68.7	75.5
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	29.8	not reported	30.0	0.0	0.0	not reported	not reported
Shareholders' equity	$m	(293)	(350)	(365)	(373)	(380)	(384)	(390)	214	217	230	234	253

Cash flow

Operating cash flow$4.0m, Q2 FY2026

Capital expenditure$146.0k, Q2 FY2026

Omada Health, Inc., cash flow, quarterly
Line item	Unit	period not labelled2024-09-30	period not labelled2024-12-31	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$m	1.1	(6.5)	(16.1)	2.9	10.1	21.4	(11.8)	4.0
Capital expenditure	$m	0.1	0.2	0.3	0.3	0.5	0.2	0.1	0.1

Diluted shares (weighted)63.95m, Q2 FY2026

Omada Health, Inc., shares, quarterly
Line item	Unit	period not labelled2024-06-30	period not labelled2024-09-30	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	7.6	7.8	8.2	22.0	57.7	58.9	63.9

Shares outstanding: 61.22m at Aug 4, 2026, from the cover of the 10-Q filed Aug 7, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.